These lines of information would offer molecular insights into how glucose metabolism is controlled by the AMPK-MDM2/MDMX-p53 pathway in cancer cells, and potential molecule targets in the pathway, for future development of anti-cancer drugs. Here, MDM2 is linked to cancer.